These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 715173

  • 1. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
    Gibbs K, Hanka R, Walshe JM.
    Q J Med; 1978 Jul; 47(187):349-64. PubMed ID: 715173
    [Abstract] [Full Text] [Related]

  • 2. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM.
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [Abstract] [Full Text] [Related]

  • 3. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
    Merli M, Patriarca M, Loudianos G, Valente C, Riggio O, De Felice G, Petrucci F, Caroli S, Attili AF.
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
    [Abstract] [Full Text] [Related]

  • 4. Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease.
    Vieira J, Oliveira PV, Juliano Y, Warde KR, Deguti MM, Barbosa ER, Carrilho FJ, Cancado EL.
    Dig Liver Dis; 2012 Apr; 44(4):323-7. PubMed ID: 22169274
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z, Heyrovský A, Volek V.
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [Abstract] [Full Text] [Related]

  • 9. [The role of zinc in the initial treatment of Wilson's disease in children].
    Cacić M, Percl M, Jadresin O, Kolacek S.
    Lijec Vjesn; 2000 Mar; 122(3-4):77-81. PubMed ID: 10932534
    [Abstract] [Full Text] [Related]

  • 10. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
    Brewer GJ, Dick RD, Yuzbasiyan-Gurkan V, Johnson V, Wang Y.
    J Lab Clin Med; 1994 Jun; 123(6):849-58. PubMed ID: 8201263
    [Abstract] [Full Text] [Related]

  • 11. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.
    Giacchino R, Marazzi MG, Barabino A, Fasce L, Ciravegna B, Famularo L, Boni L, Callea F.
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):155-61. PubMed ID: 9646197
    [Abstract] [Full Text] [Related]

  • 12. Wilson's disease: a new gene and an animal model for an old disease.
    Cuthbert JA.
    J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis and management of Wilson's disease: results of a single center experience.
    Medici V, Trevisan CP, D'Incà R, Barollo M, Zancan L, Fagiuoli S, Martines D, Irato P, Sturniolo GC.
    J Clin Gastroenterol; 2006 Aug; 40(10):936-41. PubMed ID: 17063115
    [Abstract] [Full Text] [Related]

  • 14. [Wilson's disease ("hepatic form") in a region endemic for schistosomiasis mansoni: clinical presentation of 25 patients].
    Galizzi-Filho J, Andrade Mde O, Cota Mde M, Penna FJ, Figueiredo-Filho PP, Valadares CA, Machado-Silva R, Barquete J, de Oliveira JP, de Almeida JA.
    Arq Gastroenterol; 1998 Aug; 35(1):11-7. PubMed ID: 9711308
    [Abstract] [Full Text] [Related]

  • 15. Wilson's disease (hepatolenticular degeneration) of late adult onset: report of case.
    Fitzgerald MA, Gross JB, Goldstein NP, Wahner HW, McCall JT.
    Mayo Clin Proc; 1975 Aug; 50(8):438-42. PubMed ID: 1152537
    [Abstract] [Full Text] [Related]

  • 16. Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children.
    Müller T, Koppikar S, Taylor RM, Carragher F, Schlenck B, Heinz-Erian P, Kronenberg F, Ferenci P, Tanner S, Siebert U, Staudinger R, Mieli-Vergani G, Dhawan A.
    J Hepatol; 2007 Aug; 47(2):270-6. PubMed ID: 17449133
    [Abstract] [Full Text] [Related]

  • 17. Use of whole-body counter to study body retention of radiocopper in Wilson's disease.
    Hamamoto K, Tauxe WN, Novak LP, Goldstein NP.
    J Lab Clin Med; 1968 Nov; 72(5):754-9. PubMed ID: 5697385
    [No Abstract] [Full Text] [Related]

  • 18. Long-term body retention of radiocopper (67Cu) and the diagnosis of Wilson's disease.
    Willvonseder R, Goldstein NP, Tauxe WN.
    Mayo Clin Proc; 1974 Jun; 49(6):387-93. PubMed ID: 4835809
    [No Abstract] [Full Text] [Related]

  • 19. The pattern of the whole body distribution of radioactive copper (67Cu, 64Cu) in Wilson's Disease and various control groups.
    Walshe JM, Potter G.
    Q J Med; 1977 Oct; 46(184):445-62. PubMed ID: 413153
    [No Abstract] [Full Text] [Related]

  • 20. Diagnosis and characterization of presymptomatic patients with Wilson's disease and the use of molecular genetics to aid in the diagnosis.
    Yuzbasiyan-Gurkan V, Johnson V, Brewer GJ.
    J Lab Clin Med; 1991 Nov; 118(5):458-65. PubMed ID: 1940586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.